Vaxcell-Bio Therapeutics Co., Ltd. (KOSDAQ:323990)
5,360.00
+250.00 (4.89%)
Jul 1, 2026, 9:20 AM KST
-45.58% (1Y)
| Market Cap | 118.85B -47.5% |
| Revenue (ttm) | n/a +13,737.3% |
| Net Income | n/a |
| EPS | n/a |
| Shares Out | 23.26M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 144,130 |
| Open | 5,110.00 |
| Previous Close | 5,110.00 |
| Day's Range | 4,900.00 - 5,380.00 |
| 52-Week Range | 3,850.00 - 11,520.00 |
| Beta | 0.66 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |